Sono‐Flexocatalytic Tumor Suppression Enabled by SrTiO 3 Nanoflexocatalysts
Angewandte Chemie International Edition · 09.02.2026 · 65 (7)
DOI: 10.1002/anie.202525868 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 30.12.2025. Verfasst von Yanjia Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nanjing Medical University, Nanjing, 210009, P.R. China. Hauptthemen laut MEDLINE: Strontium, Titanium, Oxides, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Science and Technology Program, Postdoctoral Fellowship Program of CPSF.
Abstract (Originalsprache)
Despite piezocatalytic tumor therapy offers a promising non‐invasive modality for disease treatment, its application is fundamentally limited by the requirement for non‐centrosymmetric piezocatalysts. To solve this critical issue, we present a novel “sono‐flexocatalytic therapy” (SFT) strategy using centrosymmetric strontium titanate (SrTiO 3 ) nanocatalysts. Under ultrasound irradiation, SrTiO 3 generates significant flexoelectric polarization due to the induced strain gradients, effectively separating charges. This drives robust redox reactions on the nanocatalyst surfaces, producing abundant cytotoxic reactive oxygen species (ROS) such as hydroxyl radicals and superoxide anions within tumor cells. The resultant ROS surge induces severe oxidative stress, mitochondrial dysfunction, and ultimately apoptosis, effectively suppressing tumor growth as validated by both in vitro and in vivo studies. Furthermore, theoretical simulations elucidate the specific strain‐gradient dependent sono‐flexocatalytic mechanism. This work pioneers sono‐flexocatalytic tumor therapy by leveraging ultrasound‐triggered flexoelectricity in SrTiO 3 nanocatalysts, thereby not only introducing centrosymmetric biomaterials into sonocatalytic treatments but also establishing a new paradigm for pancatalytic medicine with broad material applicability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Nanjing Medical University, Nanjing, 210009, P.R. China.
- Center of Interventional Radiology and Vascular Surgery, Department of Ultrasound, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, P.R. China.
- Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, P.R. China.
- Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P.R. China.
- Department of Ultrasound, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210000, P.R. China.
ORCID-Profile: Yu Chen
Förderung
- National Natural Science Foundation of China
- Shanghai Science and Technology Program
- Postdoctoral Fellowship Program of CPSF
- National Science and Technology Major Project of the Ministry of Science and Technology of China
- Jiangsu Provincial Natural Science Foundation Distinguished Young Fund
- China Postdoctoral Science Foundation
Zitieren
APA
Lu, Y., Lu, J., Hua, M., Wu, R., Sun, T., Huang, H., Hu, Z., Guo, J., & Chen, Y. (2026). Sono‐Flexocatalytic Tumor Suppression Enabled by SrTiO 3 Nanoflexocatalysts. Angewandte Chemie International Edition, 65(7). https://doi.org/10.1002/anie.202525868
Vancouver
Lu Y, Lu J, Hua M, Wu R, Sun T, Huang H, et al. Sono‐Flexocatalytic Tumor Suppression Enabled by SrTiO 3 Nanoflexocatalysts. Angewandte Chemie International Edition. 2026;65(7). doi:10.1002/anie.202525868
BibTeX
@article{Lu2026,
author = {Lu, Yanjia and Lu, Jian and Hua, Mengying and Wu, Ruohui and Sun, Tong and Huang, Hui and Hu, Zhongqian and Guo, Jinhe and Chen, Yu},
title = {Sono‐Flexocatalytic Tumor Suppression Enabled by SrTiO 3 Nanoflexocatalysts},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {7},
doi = {10.1002/anie.202525868}
}
EUVIMED